Safety Evaluation of Sclerotium from a Medicinal Mushroom, Lignosus cameronensis (Cultivar): Preclinical Toxicology Studies

Twenty-eight days subacute toxicity studies performed in rats using sclerotial powder of Lignosus cameronensis cultivar was conducted to assess its safety for consumption prior to other scientific investigations on its medicinal benefits, nutraceutical or pharmaceutical application of the mushroom....

Full description

Bibliographic Details
Main Authors: Sook-Shien Lee, Nget-Hong Tan, Jayalakshmi Pailoor, Shin-Yee Fung
Format: Article
Language:English
Published: Frontiers Media S.A. 2017-09-01
Series:Frontiers in Pharmacology
Subjects:
Online Access:http://journal.frontiersin.org/article/10.3389/fphar.2017.00594/full
_version_ 1819199943930281984
author Sook-Shien Lee
Nget-Hong Tan
Jayalakshmi Pailoor
Shin-Yee Fung
author_facet Sook-Shien Lee
Nget-Hong Tan
Jayalakshmi Pailoor
Shin-Yee Fung
author_sort Sook-Shien Lee
collection DOAJ
description Twenty-eight days subacute toxicity studies performed in rats using sclerotial powder of Lignosus cameronensis cultivar was conducted to assess its safety for consumption prior to other scientific investigations on its medicinal benefits, nutraceutical or pharmaceutical application of the mushroom. The study was conducted at 250, 500, and 1000 mg/kg sclerotial powder of L. cameronensis cultivar (n = 5 for each respective dose, on both male and female groups) while control groups received only distilled water. At the end of the study (29th day), the animals were sacrificed followed by blood and organs collection for analysis. Subacute toxicity studies done shows that sclerotial powder of L. cameronensis cultivar at 250, 500, and 1000 mg/kg did not induce treatment related changes on behavioral patterns, gross physical appearance, growth pattern, body weight gain, values of hematological and clinical biochemical panels as well as histopathological findings on kidney, spleen, heart, lung and liver of the experimental rats. The no-observed-adverse-effect level dose for sclerotial powder of L. cameronensis cultivar in 28-days sub-acute toxicity study is determined to be 1000 mg/kg.
first_indexed 2024-12-23T03:24:22Z
format Article
id doaj.art-c4eb830c757144d9984297a0161686f2
institution Directory Open Access Journal
issn 1663-9812
language English
last_indexed 2024-12-23T03:24:22Z
publishDate 2017-09-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Pharmacology
spelling doaj.art-c4eb830c757144d9984297a0161686f22022-12-21T18:01:54ZengFrontiers Media S.A.Frontiers in Pharmacology1663-98122017-09-01810.3389/fphar.2017.00594272664Safety Evaluation of Sclerotium from a Medicinal Mushroom, Lignosus cameronensis (Cultivar): Preclinical Toxicology StudiesSook-Shien Lee0Nget-Hong Tan1Jayalakshmi Pailoor2Shin-Yee Fung3Department of Molecular Medicine, Faculty of Medicine, University of MalayaKuala Lumpur, MalaysiaDepartment of Molecular Medicine, Faculty of Medicine, University of MalayaKuala Lumpur, MalaysiaDepartment of Pathology, Faculty of Medicine, University of MalayaKuala Lumpur, MalaysiaDepartment of Molecular Medicine, Faculty of Medicine, University of MalayaKuala Lumpur, MalaysiaTwenty-eight days subacute toxicity studies performed in rats using sclerotial powder of Lignosus cameronensis cultivar was conducted to assess its safety for consumption prior to other scientific investigations on its medicinal benefits, nutraceutical or pharmaceutical application of the mushroom. The study was conducted at 250, 500, and 1000 mg/kg sclerotial powder of L. cameronensis cultivar (n = 5 for each respective dose, on both male and female groups) while control groups received only distilled water. At the end of the study (29th day), the animals were sacrificed followed by blood and organs collection for analysis. Subacute toxicity studies done shows that sclerotial powder of L. cameronensis cultivar at 250, 500, and 1000 mg/kg did not induce treatment related changes on behavioral patterns, gross physical appearance, growth pattern, body weight gain, values of hematological and clinical biochemical panels as well as histopathological findings on kidney, spleen, heart, lung and liver of the experimental rats. The no-observed-adverse-effect level dose for sclerotial powder of L. cameronensis cultivar in 28-days sub-acute toxicity study is determined to be 1000 mg/kg.http://journal.frontiersin.org/article/10.3389/fphar.2017.00594/fullLignosus cameronensissclerotiumtoxicityhematologicalhistopathological
spellingShingle Sook-Shien Lee
Nget-Hong Tan
Jayalakshmi Pailoor
Shin-Yee Fung
Safety Evaluation of Sclerotium from a Medicinal Mushroom, Lignosus cameronensis (Cultivar): Preclinical Toxicology Studies
Frontiers in Pharmacology
Lignosus cameronensis
sclerotium
toxicity
hematological
histopathological
title Safety Evaluation of Sclerotium from a Medicinal Mushroom, Lignosus cameronensis (Cultivar): Preclinical Toxicology Studies
title_full Safety Evaluation of Sclerotium from a Medicinal Mushroom, Lignosus cameronensis (Cultivar): Preclinical Toxicology Studies
title_fullStr Safety Evaluation of Sclerotium from a Medicinal Mushroom, Lignosus cameronensis (Cultivar): Preclinical Toxicology Studies
title_full_unstemmed Safety Evaluation of Sclerotium from a Medicinal Mushroom, Lignosus cameronensis (Cultivar): Preclinical Toxicology Studies
title_short Safety Evaluation of Sclerotium from a Medicinal Mushroom, Lignosus cameronensis (Cultivar): Preclinical Toxicology Studies
title_sort safety evaluation of sclerotium from a medicinal mushroom lignosus cameronensis cultivar preclinical toxicology studies
topic Lignosus cameronensis
sclerotium
toxicity
hematological
histopathological
url http://journal.frontiersin.org/article/10.3389/fphar.2017.00594/full
work_keys_str_mv AT sookshienlee safetyevaluationofsclerotiumfromamedicinalmushroomlignosuscameronensiscultivarpreclinicaltoxicologystudies
AT ngethongtan safetyevaluationofsclerotiumfromamedicinalmushroomlignosuscameronensiscultivarpreclinicaltoxicologystudies
AT jayalakshmipailoor safetyevaluationofsclerotiumfromamedicinalmushroomlignosuscameronensiscultivarpreclinicaltoxicologystudies
AT shinyeefung safetyevaluationofsclerotiumfromamedicinalmushroomlignosuscameronensiscultivarpreclinicaltoxicologystudies